Center of Excellence (Beijing)
Dr. Xunwei Wu is a Principal Investigator in Shandong Provincial Key Laboratory of Oral Biomedicine and Laboratory for Tissue Engineering and Regeneration, School of Stomatology, Shandong University, Jinan, Shandong, China. He received his bachelor’s degree from Zhejiang University and a Ph.D. from Fudan University, Shanghai, China.
Dr. Wu did his first postdoctoral training at Max-Planck-Institute of Biochemistry, Germany, he generated skin conditional knockout mouse model for studying skin/hair development in vivo. And for the second postdoctoral training at Harvard Medical School, he established a novel in vivo cyst assay to study the function of human keratinocytes in vivo.
His research group currently focuses on in vivo human skin regeneration by using culture-expanded cells. Recently, his group established a new system to efficiently isolate and culture skin stem cell including both epidermal and dermal cells, and the culture system could maintain in vivo regeneration potential of skin cells after expansion. By using the culture-expanded cells, his group generated a novel mouse model with a full-thickness human skin containing mature cycling hair follicle, and the model that showed the wound healing procedure of the regenerate skin was similar to that of normal human skin. The new mouse model with regeneration of human skin provides a platform to study human skin diseases including in vivo aging process and underlying mechanisms.
Case report of severe coronary artery tortuosity with coexisting connective tissue disease.
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc Feb, 2023 | Pubmed ID: 36762928
Surgery after BRAF-directed therapy is associated with improved survival in BRAF V600E mutant Anaplastic Thyroid Cancer.
Thyroid : official journal of the American Thyroid Association Feb, 2023 | Pubmed ID: 36762947
Occupational exposure to diesel engine exhaust and serum levels of microRNAs in a cross-sectional molecular epidemiology study in China.
Environmental and molecular mutagenesis Feb, 2023 | Pubmed ID: 36762959
Simple Ether-Directed Enantioselective C(sp3)-H Borylation of Cyclopropanes Enabled by Iridium Catalysis.
Angewandte Chemie (International ed. in English) Feb, 2023 | Pubmed ID: 36762972
Predictors for short-term successful weaning from continuous renal replacement therapy: a systematic review and meta-analysis.
Renal failure Dec, 2023 | Pubmed ID: 36762988
Exploring Spectrum-based Molecular Descriptors for Reaction Performance Prediction.
Chemistry, an Asian journal Feb, 2023 | Pubmed ID: 36762990
In vivo screening unveils pervasive RNA-binding protein dependencies in leukemic stem cells and identifies ELAVL1 as a therapeutic target.
Blood cancer discovery Feb, 2023 | Pubmed ID: 36763002
Metabolic characterization and GAPDH dependent regulation of ENaC in hPheo1 wild-type and SDHB knockdown cells.
Endocrinology Feb, 2023 | Pubmed ID: 36763043
Robot-assisted resection of multiple lung nodules through combination of intercostal incisions and a subxiphoid incision as a utility port.
The international journal of medical robotics + computer assisted surgery : MRCAS Feb, 2023 | Pubmed ID: 36763095
Improved Vδ2 T cells recovery correlates to reduced incidences of mortality and relapse in acute myeloid leukemia after hematopoietic transplantation.
Annals of hematology Feb, 2023 | Pubmed ID: 36763109
Exosomal lincROR promotes docetaxel resistance in prostate cancer through a β-catenin/HIF-1α positive feedback loop.
Molecular cancer research : MCR Feb, 2023 | Pubmed ID: 36763128
Co-dependent regulation of p-BRAF and potassium channel KCNMA1 levels drives glioma progression.
Cellular and molecular life sciences : CMLS Feb, 2023 | Pubmed ID: 36763212
A phase Ib/II study of BLU-554, a fibroblast growth factor receptor 4 inhibitor in combination with CS1001, an anti-PD-L1, in patients with locally advanced or metastatic hepatocellular carcinoma.
Investigational new drugs Feb, 2023 | Pubmed ID: 36763233
Efficacy and Safety of Ertugliflozin Added to Metformin: A Pooled Population from Asia with Type 2 Diabetes and Overweight or Obesity.
Diabetes therapy : research, treatment and education of diabetes and related disorders Feb, 2023 | Pubmed ID: 36763328
Enhancing the catalytic performance of Co-N-C derived from ZIF-67 by mesoporous silica encapsulation for chemoselective hydrogenation of furfural.
Nanoscale Feb, 2023 | Pubmed ID: 36763350
Effect of Rivaroxaban vs Enoxaparin on Major Cardiac Adverse Events and Bleeding Risk in the Acute Phase of Acute Coronary Syndrome: The H-REPLACE Randomized Equivalence and Noninferiority Trial.
JAMA network open Feb, 2023 | Pubmed ID: 36763358
Quantum Fluctuation of the Quantum Geometric Tensor and Its Manifestation as Intrinsic Hall Signatures in Time-Reversal Invariant Systems.
Physical review letters Jan, 2023 | Pubmed ID: 36763382
Search for Cosmic-Ray Boosted Sub-GeV Dark Matter Using Recoil Protons at Super-Kamiokande.
Physical review letters Jan, 2023 | Pubmed ID: 36763398
99.92%-Fidelity cnot Gates in Solids by Noise Filtering.
Physical review letters Jan, 2023 | Pubmed ID: 36763408
Curvature-Regulated Multiphase Patterns in Tori.
Physical review letters Jan, 2023 | Pubmed ID: 36763422
1Center of Excellence (Beijing), Becton Dickinson Medical Devices (Shanghai) Co Ltd,
2Beijing Key Laboratory of Pediatric Respiratory Infectious Diseases, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, Laboratory of Infection and Virology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health,
3Research Unit of Critical Infection in Children, 2019RU016, Chinese Academy of Medical Sciences
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유